168 related articles for article (PubMed ID: 31569112)
1. A Review of Sclerosing Foam Stability in the Treatment of Varicose Veins.
Bai T; Liu Y; Jiang W; Li Y; Liu J; Yu C; Fan Y
Dermatol Surg; 2020 Feb; 46(2):249-257. PubMed ID: 31569112
[TBL] [Abstract][Full Text] [Related]
2. A Novel Compound Sclerosant: Polidocanol-Bleomycin Foam.
Hanshu Z; Shaohua L; Anwei C
Dermatol Surg; 2020 Dec; 46(12):1712-1714. PubMed ID: 32769523
[TBL] [Abstract][Full Text] [Related]
3. Stability of foam in sclerotherapy: differences between sodium tetradecyl sulfate and polidocanol and the type of connector used in the double-syringe system technique.
Rao J; Goldman MP
Dermatol Surg; 2005 Jan; 31(1):19-22. PubMed ID: 15720090
[TBL] [Abstract][Full Text] [Related]
4. Sclerosing foam in the treatment of varicose veins and telangiectases: history and analysis of safety and complications.
Frullini A; Cavezzi A
Dermatol Surg; 2002 Jan; 28(1):11-5. PubMed ID: 11991262
[TBL] [Abstract][Full Text] [Related]
5. The Effect of Pushing Rate on Foam Stability in the Tessari Method.
Azmoun S; Liu Y; Bian K; Chen A; Liu S
Dermatol Surg; 2024 Jun; 50(6):542-545. PubMed ID: 38460194
[TBL] [Abstract][Full Text] [Related]
6. Polidocanol concentration and time affect the properties of foam used for sclerotherapy.
VAN Deurzen B; Ceulen RP; Tellings SS; VAN DER Geld C; Nijsten T
Dermatol Surg; 2011 Oct; 37(10):1448-55. PubMed ID: 21790848
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the Safety and Efficacy of Foam Sclerotherapy With 1: 2 Polidocanol to Air Ratio Versus 1: 4 Ratio for the Treatment of Reticular Veins of the Lower Extremities.
Hoss E; Kollipara R; Boen M; Alhaddad M; Goldman MP
Dermatol Surg; 2020 Dec; 46(12):1715-1720. PubMed ID: 32947299
[TBL] [Abstract][Full Text] [Related]
8. A new automated system for the preparation of sclerosant foam: A study of the physical characteristics produced and the device settings required.
Roche E; Pons R; Roche O; Puig A
Phlebology; 2020 Oct; 35(9):724-733. PubMed ID: 32635818
[TBL] [Abstract][Full Text] [Related]
9. Effects of sulodexide on stability of sclerosing foams.
Critello CD; Fiorillo AS; Cristiano MC; de Franciscis S; Serra R
Phlebology; 2019 Apr; 34(3):191-200. PubMed ID: 29871533
[TBL] [Abstract][Full Text] [Related]
10. Sclerotherapy: a study comparing polidocanol in foam and liquid form.
Uncu H
Phlebology; 2010 Feb; 25(1):44-9. PubMed ID: 20118346
[TBL] [Abstract][Full Text] [Related]
11. Does the relative silicone content of different syringes affect the stability of foam in sclerotherapy?
Lai SW; Goldman MP
J Drugs Dermatol; 2008 Apr; 7(4):399-400. PubMed ID: 18459524
[TBL] [Abstract][Full Text] [Related]
12. An Investigation on the Influence of Hyaluronic Acid on Polidocanol Foam Stability.
Chen AW; Liu YR; Li K; Liu SH
Dermatol Surg; 2016 Jan; 42(1):56-8. PubMed ID: 26671207
[TBL] [Abstract][Full Text] [Related]
13. Preliminary experience with a new sclerosing foam in the treatment of varicose veins.
Tessari L; Cavezzi A; Frullini A
Dermatol Surg; 2001 Jan; 27(1):58-60. PubMed ID: 11231246
[TBL] [Abstract][Full Text] [Related]
14. Effect of Multiple Factors on Foam Stability in Foam Sclerotherapy.
Bai T; Jiang W; Chen Y; Yan F; Xu Z; Fan Y
Sci Rep; 2018 Oct; 8(1):15683. PubMed ID: 30356108
[TBL] [Abstract][Full Text] [Related]
15. An investigation on the influence of glycerin on sclerosant foam stability.
Peterson JD; Goldman MP
Phlebology; 2011 Sep; 26(6):232-4. PubMed ID: 21415429
[TBL] [Abstract][Full Text] [Related]
16. Significant endothelin release in patients treated with foam sclerotherapy.
Frullini A; Barsotti MC; Santoni T; Duranti E; Burchielli S; Di Stefano R
Dermatol Surg; 2012 May; 38(5):741-7. PubMed ID: 22540861
[TBL] [Abstract][Full Text] [Related]
17. A comparison of different surfactants on foam stability in foam sclerotherapy in vitro.
Bai T; Liu Y; Liu J; Yu C; Jiang W; Fan Y
J Vasc Surg; 2019 Feb; 69(2):581-591.e1. PubMed ID: 29954633
[TBL] [Abstract][Full Text] [Related]
18. Double-blind prospective comparative trial between foamed and liquid polidocanol and sodium tetradecyl sulfate in the treatment of varicose and telangiectatic leg veins.
Rao J; Wildemore JK; Goldman MP
Dermatol Surg; 2005 Jun; 31(6):631-5; discussion 635. PubMed ID: 15996411
[TBL] [Abstract][Full Text] [Related]
19. Novel developments in foam sclerotherapy: Focus on Varithena® (polidocanol endovenous microfoam) in the management of varicose veins.
Star P; Connor DE; Parsi K
Phlebology; 2018 Apr; 33(3):150-162. PubMed ID: 28166694
[TBL] [Abstract][Full Text] [Related]
20. Modified Tessari Tourbillon technique for making foam sclerotherapy with silicone-free syringes.
Whiteley MS; Patel SB
Phlebology; 2015 Oct; 30(9):614-7. PubMed ID: 25288590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
